Phoenix Children's Hospital has announced a groundbreaking new institute slated to analyze patients' unique genetic makeup to create personalized treatment plans.
The institute is to focus on precision medicine, essentially an analysis of seriously ill patients and their disease at the molecular level. Precision medicine is used to create precise and personalized diagnoses and treatment plans, especially for those patients who have not responded to traditional therapies.
The Chan Soon-Shiong Children's Precision Medicine Institute at Phoenix Children's is billed as a partnership between the hospital and Dr. Patrick Soon-Shiong, a surgeon and healthcare entrepreneur who has until now focused on adult populations.
With the institute, Phoenix Children's will become the national hub for pediatric genomic research and precision medicine, the hospital announced.
Plans call for the hospital to house one of the few supercomputers in the country dedicated to genomic sequencing and analysis. Such analysis is used to create "specific and targeted therapeutic remedies based on the individual's unique genetic makeup," the hospital says.
And the analysis can be completed with speed. The institute is to offer complete genomic sequencing and analysis in "an unprecedented seven days," the hospital states.
"Current genome sequencing takes time," says Robert Meyer, president and CEO of Phoenix Children's Hospital. "And that's something that these patients don't have. The mission is to develop innovative and effective diagnostics and therapies for young patients, while empowering physicians with the most up-to-date research and therapeutic models available, all to deliver potentially life-saving treatments.
"The Chan Soon-Shiong Children's Precision Medicine Institute will fundamentally alter the way pediatric health care is delivered around the world," Meyer says.
Got a tip? Send it to: Ashley Cusick.